Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "Anti-inflammatory effect via Andrographis paniculata constituents/immune modulation/heat-clearing action" does not refer to a single canonical therapeutic target, but rather describes the broad pharmacological actions attributed to multiple bioactive compounds found within the medicinal plant *Andrographis paniculata*. The primary active molecule is andrographolide—a diterpene lactone—alongside related analogs such as neoandrographolide. These compounds exert their effects by modulating several key inflammatory signaling pathways: most notably inhibiting NF-kB activation and downstream proinflammatory cytokines like TNF-alpha and IL-6; suppressing MAPK/iNOS activity; regulating chemokine gene expression; and influencing TLR/MyD88-dependent immune responses. Traditionally classified as a “cold” herb in Chinese medicine for its heat-clearing properties, *A. paniculata* is widely used for treating infections, inflammation-related conditions such as sepsis, respiratory tract infections, autoimmune diseases, and even cancer adjunctively. However, because this entry refers collectively to plant extracts’ mechanisms rather than an individual receptor/enzyme/transporter/protein target recognized by modern pharmacology nomenclature systems—it should be flagged as not a true therapeutic target but rather an herbal mechanism profile.
The anti-inflammatory and immunomodulatory effects are mediated by: Inhibition of NF-kB pathway activation, reducing transcription of pro-inflammatory genes such as TNF-alpha and IL-6; Downregulation of iNOS expression and NO production via p38MAPK pathway suppression; Modulation of chemokine gene expression including ENA-78, RANTES, MCP-1 in inflamed tissues/cells; Suppression of TLR/MyD88/NF-kB signaling axis in immune cells leading to reduced cytokine storm responses during infection or sepsis models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Andrographis paniculata constituent-mediated anti-inflammatory and immune modulation pathways.